Showing posts with label Vaccine. Show all posts
Showing posts with label Vaccine. Show all posts

Tuesday, November 10, 2026

Adult vaccination remains low, elderly miss cover against flu, pneumonia and shingles

Adult vaccination remains low, elderly miss cover against flu, pneumonia and shingles 

10.11.2026  TIMES BHOPAL

Anuja.Jaiswal@timesofindia.com New Delhi: 

Despite vaccines being available to prevent several infections that can be particularly serious for older people, adult immunisation remains low in India. Influenza, pneumococcal disease and shingles are among the key vaccine-preventable illnesses that pose a risk to older people, but studies point to poor awareness and low uptake of these vaccines. 

Ahead of World Immunisation Day Tuesday (Nov 10), the findings highlight a significant gap in protection beyond childhood. A multicentre study of 4,998 people aged 60 and above across Chennai, Ballabgarh, Kolkata and Pune found only 1.4% had ever received an influenza vaccine. While just 19.7% had heard of influenza, 35.9% considered vaccines safe and 65.3% were unwilling to pay for vaccination. 


However, uptake rose to 29.7% when vaccines were offered free of cost at community health camps. Published in ‘BMC Public Health’ in 2026, the study highlights gaps in awareness, acceptance and access to vaccination among older people. The disease burden is substantial. A separate study published in ‘Influenza and Other Respiratory Viruses’ in April 2026 estimated that influenza among Indians aged 60 and above accounted for 5.3 million respiratory infections, 36,149 hospitalisations and 84,613 deaths in 2021. 

The researchers found that an annual influenza vaccination programme for older adults could be cost-effective under most of the scenarios assessed. “Influenza and pneumococcal infections cause a significant burden among older Indians, accounting for an estimated 1.2 lakh deaths annually. Studies show that influenza vaccination can reduce influenza-associated pneumonia cases by 52% and deaths by 70%, while pneumococcal vaccination can lower hospitalisations by around 27% and deaths by 34%. 

Yet vaccination coverage among the elderly remains very low,” said Dr Neetu Jain, senior consultant, pulmonology, critical care and sleep medicine, PSRI Hospital. “Annual flu and pneumococcal vaccination is particularly important for people above 60 and those with COPD, asthma, diabetes or heart disease, as infections can lead to serious complications, including respiratory failure and prolonged hospitalisation,” she said. 

Evidence is also emerging of the economic value of pneumococcal vaccination. A study published in ‘Infectious Diseases and Therapy’ in Oct 2026 examined the cost-effectiveness of a single dose of the 20-valent pneumococcal conjugate vaccine (PCV20) for older adults and people at higher risk. It found that the vaccine could be a cost-effective option compared with existing vaccination approaches. Another infection of concern among older adults is shingles, caused by reactivation of the virus responsible for chicken pox. It can lead to prolonged nerve pain, known as postherpetic neuralgia. 

A 2026 paper in ‘Indian Journal of Community Medicine’ noted the lack of robust population-based data on shingles in India, while citing an estimate of around 45 lakh cases annually. An Indian phase-3 trial of the recombinant zoster vaccine, published in ‘Vaccine’ in 2025, reported an immune response in 85.7% of participants aged 50 and above. “Influenza and pneumococcal vaccines can reduce cases of severe illness, hospitalisation and complications, particularly among older people and those with chronic conditions such as diabetes, heart disease and COPD. 

Both are non-live vaccines and can be given to elderly people, including those with multiple conditions,” said Dr Jatin Ahuja, infectious disease specialist, Apollo Hospitals, Delhi. “India also needs to expand adult vaccination to cover shingles. The two-dose recombinant zoster vaccine is recommended for adults aged 50 and above and offers over 90% protection. Tdap or Td boosters, hepatitis B and, where indicated, Covid-19 and RSV vaccines should also be considered,” he said. Goa has taken a step towards expanding vaccination beyond childhood through its Lifecourse Immunisation Policy 2026-2036, launched in Sept. 

The policy identifies influenza, pneumococcal and hepatitis B vaccination among its priorities for elderly, those with chronic illnesses, immunocompromised individuals and healthcare workers. 

Tuesday, December 30, 2025

Buffalo dies of dog bite in UP, villagers who had ‘raita’ made from its milk rush for vaccine

Buffalo dies of dog bite in UP, villagers who had ‘raita’ made from its milk rush for vaccine 

Krishna.Chaudhary@timesofindia.com 30.12.2025

Bareilly : More than 200 residents of Pipraul village in Uttar Pradesh’s Badaun district suddenly queued up in large groups at a local health centre for precautionary anti-rabies vaccines after widespread speculation that ‘raita’, a side dish made up of yogurt, served at a funeral feast was from a buffalo which had died due to rabies after being bitten by a ‘mad’ dog. The feast was held on Dec 23 in memory of late Oran Sahu, a resident of Pipraul — a village with a population of around 1,800 people, as per official records. 



Locals said villagers from nearby settlements also attended the ‘tehravi’ ceremony. One of them said that the buffalo belonged to Sahu’s cousin who used its milk to prepare the ‘raita’ dish. Three days later, the buffalo died, sparking panic in and around the village. “People are anxious because no one knows much about rabies, and there is more hearsay than facts spreading here... Nearly 250 residents have taken the anti-rabies vaccine already, and others are lining up to do the same. Most of them have left all their work to get this done first,” said Deepak Kumar, husband of village pradhan Renu Devi. He added villagers were particularly worried since the dog — believed to have bitten the cattle — could not be traced. Also, the buffalo was buried soon after its death without a postmortem, leaving health officials without a clue regarding the exact cause, Kumar said. 

A medical team has since been stationed in the village to monitor the situation and counsel residents. Health authorities said that they are vaccinating anyone seeking “precautionary protection”. Budaun’s chief medical officer, Dr Rameshwar Mishra, said, “In two days, 247 residents from Pipraul came to our facility for vaccinations en masse. On Monday alone, 110 people got the shots. 

Counselling is also underway, and villagers are being advised not to panic.” Experts, meanwhile, said that current evidence does not support the widespread belief that rabies can be transmitted through milk. Dr Abhijeet Pawde, principal scientist and in-charge of IVRI (Indian Veterinary Research Institute) Polyclinic, told TOI , “Studies so far do not conclusively show milk consumption as a mode of rabies transmission. No scientific literature confirms that rabies passes into milk in such cases. Transmission risk is higher via direct exposure to saliva or tissue.” Budaun’s chief medical officer said in two days, 247 residents from Pipraul came to the facility for vaccinations en masse. ‘On Monday alone, 110 people got the shots’

Friday, April 29, 2022

VACCINATION


NRIs and Sputnik beneficiaries unable to get boosters now

Neha Madaan TNN

Pune : Thousands of NRIs, who took Covid vaccines other than Covishield or Covaxin and are back in India, now face a unique problem: they are unable to get boosters. Even those who took the AstraZeneca vaccine, which is Covishield in India, are in a fix because their details are not on CoWin.

Sumit Sachdeva, a working professional from Mumbai, said: “My mother was in Australia last year where she got two doses of the AstraZeneca vaccine. She later returned to India and is now due for her precaution dose. But when we visited a hospital, we were told she can’t get one because there’s no way to register on CoWin the doses she took in Australia. ”

Many NRIs had taken vaccines such as Pfizer abroad. Scores of them had also moved back to India. But they’re unable to get boost- ers as the government only allowed homologous doses.

Asenior official from the health ministry said it would not be possible to import foreign vaccines for a set of beneficiaries. The official, however, added: “The ministry has been getting queries from beneficiaries on this issue. And the matter may be discussed soon by officials. ”

Those who took Sputnik are also having trouble getting boosters. There has been no update from the health ministry on Sputnik Vprecaution doses.

NEWS TODAY 17.11.2026